title: Neostigmine reversal doesn't improve postoperative respiratory safety.
authors.forename: Matthew J
authors.initials: MJ
authors.lastname: Meyer
authors.forename: Brian T
authors.initials: BT
authors.lastname: Bateman
authors.forename: Tobias
authors.initials: T
authors.lastname: Kurth
authors.forename: Matthias
authors.initials: M
authors.lastname: Eikermann
mesh_terms: D000328:Adult; D000368:Aged; D016022:Case-Control Studies; D005260:Female; D006801:Humans; D007430:Intraoperative Care / Q000379:methods; D008297:Male; D008875:Middle Aged; D009388:Neostigmine / Q000008:administration & dosage / Q000009:adverse effects*; D009466:Neuromuscular Blocking Agents / Q000008:administration & dosage / Q000009:adverse effects*; D061214:Patient Safety; D011183:Postoperative Complications / Q000139:chemically induced / Q000503:physiopathology; D011379:Prognosis; D012016:Reference Values; D012131:Respiratory Insufficiency / Q000139:chemically induced* / Q000453:epidemiology; D028761:Withholding Treatment
chemical_list: D009466:Neuromuscular Blocking Agents; D009388:Neostigmine